Elara Caring (JHH/CIMA Holdings Inc., CIMA Healthcare Management Inc., CIMA Hospice of Texarkana LLC, CIMA Hospice of East Texas LLC, CIMA Hospice of El Paso LP)
Outcome
Elara Caring and its CIMA Hospice subsidiaries paid $4.2 million to resolve False Claims Act allegations that their Texarkana, Texas location knowingly submitted false claims for hospice patients who were not terminally ill, covering a seven-year period from 2014 to 2020; additional allegations covered two other Texas locations between 2015 and 2021.
Details
Elara Caring / CIMA Hospice — Hospice Billing for Non-Terminally Ill Patients in Texas (2024)
Outcome: Elara Caring and its wholly owned CIMA Hospice subsidiaries paid $4.2 million to resolve False Claims Act allegations that they knowingly submitted false claims to Medicare for hospice services provided to patients who were not terminally ill under Medicare's six-months-or-less eligibility standard, covering facilities in Texarkana and two other Texas locations.
Elara Caring is a private equity-owned home health and hospice company operating in rural and underserved markets. The CIMA Hospice entities — JHH/CIMA Holdings Inc., CIMA Healthcare Management Inc., CIMA Hospice of Texarkana LLC, CIMA Hospice of East Texas LLC, and CIMA Hospice of El Paso LP — were acquired by Elara Caring and operated under Elara's corporate umbrella during the relevant period.
The primary allegations concerned Elara Caring's Texarkana, Texas location, which previously operated as CIMA Hospice of Texarkana. The government alleged that from 2014 to 2020, this location knowingly submitted false claims and knowingly retained overpayments for hospice services provided to patients who did not qualify for the Medicare hospice benefit because they were not terminally ill. Additional allegations covered two other Texas locations operated by the CIMA entities, involving patients between 2015 and 2021.
The settlement was announced May 1, 2024 by the DOJ. The qui tam lawsuit was filed by Aneko Jackson, a former Elara Caring employee with knowledge of the billing practices. Jackson received $672,000 — 16% of the government's recovery — as her relator share under the False Claims Act's whistleblower provisions.
The settlement illustrates the recurring compliance risk in private equity-owned hospice chains operating across geographically dispersed rural locations, where clinical oversight of admissions practices and ongoing eligibility monitoring may be inadequate relative to the volume of patients served.
How Crucible Prevents This
Crucible hospice eligibility documentation controls would require that terminal prognosis certifications be supported by clinical documentation demonstrating a life expectancy of six months or less, with automated escalation to a hospice medical director for independent review when the patient's documented condition trajectory does not clearly support the prognosis. A longitudinal patient monitoring module would flag patients who have been certified for hospice for extended periods without documented decline, triggering a clinical eligibility reassessment before continued billing. Acquired-entity compliance integration protocols — particularly relevant given the CIMA-to-Elara Caring acquisition chain — would require that inherited patient census records be reviewed against current eligibility criteria within 90 days of acquisition.
Don't let this happen to your organization. See how Crucible works.
See How Crucible Works